Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sinusitis Hevert SL
- Development stage
- Phase 4
- Lead developer
- Hevert-Arzneimittel
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Sinusitis Hevert SL is a homeopathic complex medicine developed by Hevert-Arzneimittel for the treatment of inflammatory diseases of the upper respiratory tract, specifically acute and chronic rhinosinusitis. It is a combination of eleven homeopathic active ingredients, including *Apis mellifica*, *Baptisia tinctoria*, *Cinnabaris*, *Echinacea*, *Hepar sulfuris*, *Kalium bichromicum*, *Lachesis mutus*, *Luffa operculata*, *Mercurius bijodatus*, *Silicea*, and *Spongia tosta*. The preparation is intended to reduce inflammation, decongest the nasal mucosa, and alleviate symptoms such as sinus pressure and headache. As a homeopathic remedy, it is designed to stimulate the body's self-healing powers and is often used as an alternative or adjunct to conventional treatments like antibiotics or decongestants.
- Brand names
- Sinusitis Hevert SL
- Other names
- Sinusitis HevertHevert Sinus Relief SL
Beyond the preview
Go deeper on Sinusitis Hevert SL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sinusitis Hevert SL.